Emerald Health Pharmaceuticals & The Holy Grail of MS research

*I got chills reading thru a release on GlobalNewsWire.com- Thanks to Reddit User u/orangeseas and This Thread on r/MultipleSclerosis.


Emerald Health Pharmaceuticals has shared pre-clinical data of their proprietary CBD derived medication EHP-101, an oral formulation of a patented cannabidiol (CBD)-derived new chemical entity (NCE),VCE-004.8 

“Restoring the myelin sheath around nerves, or remyelination, would be considered a ‘Holy Grail’ outcome in the treatment of MS,” said Jim DeMesa, MD, CEO of Emerald Health Pharmaceuticals. “Our new data demonstrate that EHP-101 can generate new myelin sheaths on the nerves damaged by MS, which is not reversible naturally in the disease. These preclinical data provide the first evidence of remyelination with our lead clinical-stage drug product candidate and provide promising evidence for the possibility to treat, and potentially reverse, several forms of MS in the future.”

Now it should be noted- that this has only been accomplished in murine ( mouse ) models, but they are entering phase 2 of Clinical Trials taking place soon.  scale their research hopefully they can squeeze a modern miracle.

https://multiplesclerosisnewstoday.com/news-posts/2019/07/02/emerald-health-pharmaceuticals-demonstrates-repair-of-nerve-damage-related-to-multiple-sclerosis/